← back to search

Stefania Galimberti

University of South Carolina · US
Area of research
Oncology · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Medicine, Chemotherapy-induced peripheral neuropathy, Peripheral neuropathy, Traumatic brain injury, Quality of life (healthcare), and Reliability (semiconductor).
h-index
citations
1,992
works
12
NIH funding
primary concept
email

Recent publications

Early systemic insults following traumatic brain injury: association with biomarker profiles, therapy for intracranial hypertension, and neurological outcomes—an analysis of CENTER-TBI data
Intensive Care Medicine 2024cited by 28position: middledoi
The Neurological Pupil index for outcome prognostication in people with acute brain injury (ORANGE): a prospective, observational, multicentre cohort study
The Lancet Neurology 2023cited by 85position: middledoi
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden
Blood 2023cited by 39position: middledoi
Effect of frailty on 6-month outcome after traumatic brain injury: a multicentre cohort study with external validation
The Lancet Neurology 2022cited by 81position: firstdoi
OMICS in Chronic Kidney Disease: Focus on Prognosis and Prediction
International Journal of Molecular Sciences 2021cited by 33position: middledoi
Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study
Journal of Allergy and Clinical Immunology 2019cited by 86position: middledoi
Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis
JAMA Neurology 2017cited by 74position: middledoi
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
Science 2013cited by 1,033position: middledoi
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
Annals of Oncology 2013cited by 179position: middledoi
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)
European Journal of Cancer 2013cited by 46position: middledoi
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
Annals of Oncology 2012cited by 287position: middledoi
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial
Trials 2012cited by 21position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2012–2017) · 2 papers (2012–2017) · 2 papers (2012–2017)Roberto Galeotti · University of Ferrara2 papers (2012–2017) · 2 papers (2012–2017) · 2 papers (2012–2017)Roberto D’Amico · University of Modena and Reggio Emilia2 papers (2012–2017)Luca Massacesi · National Institute of Neurological Disorders and Stroke2 papers (2012–2017)Graziella Filippini · Neurological Surgery2 papers (2012–2017)Fabrizio Salvi · University of Ferrara2 papers (2012–2017) · 2 papers (2012–2017) · 1 papers (2021–2021) · 1 papers (2023–2023)Alberto Mantovani · Equilibrium Research1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2012–2012)Andrea Biondi · Associazione Italiana Ematologia Oncologia Pediatrica1 papers (2023–2023) · 1 papers (2021–2021) · 1 papers (2023–2023)Francesco Dazzi · AstraZeneca (United Kingdom)1 papers (2023–2023)